1,725
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclinical and clinical activity against metastatic colorectal cancer, particularly in combination with chemotherapy.

          Related collections

          Author and article information

          Journal
          N Engl J Med
          The New England journal of medicine
          Massachusetts Medical Society
          1533-4406
          0028-4793
          Jun 03 2004
          : 350
          : 23
          Affiliations
          [1 ] Duke University, Durham, NC, USA. hurwi004@mc.duke.edu
          Article
          350/23/2335
          10.1056/NEJMoa032691
          15175435
          c5fb83d8-ae96-43ea-8582-583850f3cca9
          Copyright 2004 Massachusetts Medical Society
          History

          Comments

          Comment on this article

          Related Documents Log